Form 4 Tracker
James Aloysius Brady

Director · 1 filing · Latest: Mar 30, 2026

Xeris Biopharma Holdings, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
XERS
James Aloysius BradyDirectorMar 30, 2026
Sale
$5.5410,834$60.0K89,166
XERS
JAMES BRADYMar 30, 2026
Proposed Sale
$5.4010,834$58.5K